Dow Down 0.22% Nasdaq Up 0.14%

Exelixis, Inc. (EXEL)

-NasdaqGS
4.11 Up 0.02(0.49%) Aug 22, 3:59PM EDT
Prev Close:4.09
Open:4.09
Bid:N/A
Ask:4.20 x 200
1y Target Est:5.93
Beta:2.26
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:4.06 - 4.14
52wk Range:3.02 - 8.41
Volume:995,701
Avg Vol (3m):3,827,480
Market Cap:801.90M
P/E (ttm):N/A
EPS (ttm):-1.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EXELUp 0.49%801.90M
AZNDown 0.19%92.26B
GSKDown 0.04%114.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.54
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine kinas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback